PASITHEA THERAPEUTICS CORP. Foreign Currency Transaction Gain (Loss), before Tax
PASITHEA THERAPEUTICS CORP. (KTTA) reported Foreign Currency Transaction Gain (Loss), before Tax of -$29.79 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2026-08-14
- PASITHEA THERAPEUTICS CORP. foreign currency transaction gain (loss), before tax for the quarter ending 2026-06-30 was -$29.79K, a 201.71% decline year-over-year.
- PASITHEA THERAPEUTICS CORP. foreign currency transaction gain (loss), before tax for the quarter ending 2026-03-31 was -$9.49K.
- PASITHEA THERAPEUTICS CORP. foreign currency transaction gain (loss), before tax for the quarter ending 2025-12-31 was $27.34K.
- PASITHEA THERAPEUTICS CORP. foreign currency transaction gain (loss), before tax for the quarter ending 2025-09-30 was -$26.25K.
- PASITHEA THERAPEUTICS CORP. foreign currency transaction gain (loss), before tax for fiscal 2025 was $30.38K.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 6 month | Foreign Currency Transaction Gain (Loss), before Tax 9 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$29.79K 10-Q · filed 2026-08-14 | -$39.28K 10-Q · filed 2026-08-14 | -$11.95K derived: sum of 3 quarters · filed 2026-08-14 | -$38.20K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$9.49K 10-Q · filed 2026-05-15 | $17.84K derived: sum of 2 quarters · filed 2026-05-15 | -$8.40K derived: sum of 3 quarters · filed 2026-05-15 | $20.89K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $27.34K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $1.09K derived: sum of 2 quarters · filed 2026-03-30 | $30.38K derived: sum of 3 quarters · filed 2026-08-14 | $30.38K 10-K · filed 2026-03-30 |
| 2025-09-30 | -$26.25K 10-Q · filed 2025-11-13 | $3.04K derived: sum of 2 quarters · filed 2026-08-14 | $3.04K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $29.29K 10-Q · filed 2026-08-14 | $29.29K 10-Q · filed 2026-08-14 | ||
| 2025-03-31 | -$7.17K 10-Q · filed 2025-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |